HHGA
Halbert Hargrove Global Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Buy |
13,685
+8,839
| +182% | +$74.5K | 0.01% | 96 |
|
|
2025
Q1 | $38.5K | Sell |
4,846
-3,544
| -42% | -$28.2K | ﹤0.01% | 150 |
|
|
2024
Q4 | $81.5K | Sell |
8,390
-4,169
| -33% | -$40.5K | ﹤0.01% | 106 |
|
|
2024
Q3 | $141K | Sell |
12,559
-221
| -2% | -$2.49K | 0.01% | 75 |
|
|
2024
Q2 | $133K | Sell |
12,780
-301
| -2% | -$3.14K | 0.01% | 76 |
|
|
2024
Q1 | $149K | Buy |
+13,081
| New | +$149K | 0.01% | 84 |
|
|
2023
Q4 | – | Sell |
-13,460
| Closed | -$137K | – | 92 |
|
|
2023
Q3 | $137K | Buy |
13,460
+899
| +7% | +$9.14K | 0.01% | 89 |
|
|
2023
Q2 | $152K | Buy |
12,561
+6
| +0% | +$73 | 0.01% | 85 |
|
|
2023
Q1 | $155K | Buy |
12,555
+371
| +3% | +$4.57K | 0.01% | 156 |
|
|
2022
Q4 | $154K | Sell |
12,184
-1,724
| -12% | -$21.8K | 0.01% | 153 |
|
|
2022
Q3 | $175K | Buy |
+13,908
| New | +$175K | 0.01% | 142 |
|